Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Adoptive T-cell therapy (ATCT) can result in tumor rejection, yet the behavior and fate of the introduced T cells remain unclear. We developed a novel bioluminescence mouse model, which enabled highly sensitive detection of T-cell signals at the single-cell level. Transferred T cells preferentially accumulated within antigen-positive tumors, relative to the unaffected areas in each mouse, and remarkably, expanded within both lymphopenic and P14 mice. This expansion was controlled and efficient, as evaluated by bioluminescence imaging (BLI) of the T-cell signals and by tumor rejection respectively. Analysis of the population dynamics of transferred T cells in ATCT of large tumors revealed that proliferation did not always follow a simple linear pattern of expansion, but showed an oscillating pattern of expansion and contraction that was often followed by a rebound, until full tumor rejection was achieved. Furthermore, visualizing the recall response showed that the transferred T cells responded expeditiously, indicating the ability of these cells to survive, establish memory and compete with endogenous T cells for as long as 1 year after rejecting the tumor.

Original publication

DOI

10.1002/eji.201141452

Type

Journal article

Journal

Eur J Immunol

Publication Date

11/2011

Volume

41

Pages

3187 - 3197

Keywords

Adoptive Transfer, Animals, Cell Separation, Cell Transplantation, Chemotaxis, Leukocyte, Female, Flow Cytometry, Immunotherapy, Adoptive, Luciferases, Renilla, Luminescent Measurements, Male, Mice, Mice, Inbred C57BL, Mice, Transgenic, Neoplasms, Experimental, T-Lymphocytes